Skip to main content
Premium Trial:

Request an Annual Quote

Ann Hanham

Ann Hanham has been appointed the chair of HTG Molecular Diagnostics' board. Hanham has more than 15 years of experience in the life science investment sector as a founding member and managing partner of BAR Capital Management. Before that, she was a managing director and general partner of Burrill & Co.